• Search
  • Helpdesk
  • Sales contact

Uncategorized

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to form scientific advisory board

Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise further in aiding pharma and biotech companies to define and implement Patient-Reported Outcomes (PROs) and electronic...

We co-organized the France Biotech Symposium on Decentralized Clinical Trials in Paris!

Date: October 18Location: PariSanté Campus in ParisOBJECTIVES:Define decentralized clinical trials, provide an update on their development and implementation in France...

Customizing eCOA questionnaire design to improve the pediatric experience

Dedicated to improve patient experience in clinical trials, Kayentis’ Clin’form solution offers the flexibility to customize questionnaire design with illustrations...

What can eDiary bring to your study?

During a clinical trial, in particular for late phase trials, it becomes increasingly important to be able to collect a...

The benefits of the eICF in patient engagement

The patient’s role in clinical trials, as well as the general image of patient care, is evolving. The patient is...